Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $75 is 91.96% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 75.11||$ 86.582|
|Low:||$ 72.66||$ 39.07|
ETFs with IONS as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|3.34%||First Trust Amex Biotech Index Fund (FBT)||+3.23 (2.36%)|
|2.93%||Principal Healthcare Innovators Index ETF (BTEC)||+1.92 (6.14%)|
|2.29%||First Trust Health Care AlphaDEX (FXH)||-2.57 (-3.42%)|
|1.65%||SPDR Series Trust SPDR S&P Biotech ETF (XBI)||+7.03 (8.80%)|
|0.62%||Vanguard Small-Cap Growth ETF (VBK)||+20.44 (12.42%)|
|*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past 100 days.|
Company Description (as filed with the SEC)
We are a leader in discovering and developing RNA-targeted therapeutics with sustained and growing revenues. We have created an efficient and broadly applicable drug discovery platform leveraging our expertise in antisense oligonucleotide therapeutics that we believe has fundamentally changed medicine and transformed the lives of people with devastating and often deadly diseases. Our large, diverse and advanced pipeline of over 40 first-in-class and/or best-in-class medicines addresses diseases across a broad range of therapeutic areas, targeting small, medium and large patient populations. We have two commercial medicines approved in major markets around the world, SPINRAZA and TEGSEDI. We have at least four medicines that have entered pivotal studies or have the potential to begin pivotal studies this year, and another six medicines that could start pivotal studies in 2020. ... More ...
Nasdaq Official Price
Apr. 23, 2019
Apr. 23, 2019